[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100443425":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":28,"responsibleParty":47,"collaborators":11,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":11,"enrollmentInfo":58,"targetDuration":11,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":70,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Institut Paoli-Calmettes","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient treated with CAR-T cells","EXPERIMENTAL",null,[13],"Other: Blood sample collection",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Blood sample collection","Blood samples collection: at Day (D)-6 and D0 before CAR-T cells injection, post injection at Day (D)3, D5,D7, D9, D11, D14, D18, D 21, Month 2 and Month 12 post injection.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Dominique GENRE, MD","CONTACT","+33491223778","drci.up@ipc.unicancer.fr",{"name":26,"role":22,"phone":23,"phoneExt":11,"email":27},"Jihane PAKRADOUNI, Pharm PhD","pakradounij@ipc.unicancer.fr",[29],{"facility":5,"status":11,"city":30,"state":11,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Marseille","13273","France","FR",{"type":35,"coordinates":36},"Point",[37,38],5.38107,43.29695,{"lat":38,"lon":37},[41,44],{"name":42,"role":22,"phone":43,"phoneExt":11,"email":24},"GENRE Dominique, MD","33(0) 4 91 22 37 78",{"name":45,"role":46,"phone":11,"phoneExt":11,"email":11},"Claude Lemarié, PharmD","PRINCIPAL_INVESTIGATOR",{"type":48,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100443425","immunological-profile-for-patients-treated-with-car-t-cells-100443425",false,"NCT05054231","Immunological Profile for Patients Treated With CAR-T Cells","SI-CART","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Planned injection of CAR-T cells within the scope of marketing authorization\n* Signed informed consent\n* French social security affiliation\n\nExclusion Criteria:\n\n* Pregnant women, or women of childbearing potential (without medically acceptable contraception) or breastfeeding women.\n* Patient in emergency situation, adult under legal protection (patient placed under tutorship, curatorship, or judicial protection) or unable to give his consent\n* Impossibility to comply with trial medical follow-up for geographic, social or psychological reasons","ALL","18 Years",{"count":59,"type":60},500,"ESTIMATED","INTERVENTIONAL",[63],"NA","In the frame of Si-CART study, blood will be collected from patients treated with CAR-T cells: before (at Day (D)-6 and D0 before cells injection), post infusion at D3, D5,D7, D9, D11, D14, D18, D 21, Month (M) 2 and M12 post injection.\n\nA cerebrospinal fluid sample will also be collected if a Cerebrospinal Fluid Analysis Lumbar puncture is performed",[66],"Hematologic Neoplasms",[68,69],"CAR-T cells","Immunological Profile","NOT_YET_RECRUITING","2021-10-07",{"date":73,"type":74},"2021-10-15","ACTUAL",{"date":76,"type":60},"2021-10-05",{"date":78,"type":60},"2026-10-05",{"name":5,"class":6},1]